Is cimepilimab an imported drug? Which manufacturer produces it?

Cemiplimab, commonly known as cemiplimab-rwlc in English and trade name Libtayo, is a high-profile immune checkpoint inhibitor widely used to treat various cancers. However, many patients still have doubts about whether this drug is imported and about its manufacturer. This article will answer this in detail.

Is cimepilimab an imported drug?

Indeed, cimepilimab is an imported drug. Its research and development and production are mainly carried out abroad, and it has been approved in many countries and marketed globally. Although this drug has not yet been approved in China, its excellent performance in the international market has fully demonstrated its remarkable efficacy and potential. For domestic patients in need, they may need to purchase the imported version of cimepilimab through specific channels. In order to ensure the reliability of drug sources, patients can seek help from some reputable overseas medical institutions, which usually have direct ties with pharmaceutical manufacturers.

Who is the manufacturer of cimepilimab?

Cimeplimab is an innovative drug jointly developed by Sanofi (Sanofi) and its partner Regeneron (Regeneron). Sanofi and Regeneron are both world-renowned biopharmaceutical companies with deep experience and outstanding capabilities in drug R&D and production. The powerful combination of these two companies provides solid backing for the successful development and marketing of cimepilimab.

In overseas markets, a box of the European version of cimepril monoclonal antibody with a specification of 350mg/7mL sells for about 4 more than 10,000 yuan. At the same time, there are American versions of original drugs available on the market, but a box of them costs more than 100,000 yuan. It is worth noting that there is no difference in the efficacy of these original drugs, and the price difference is mainly affected by national medical policies. Therefore, patients do not need to have any doubts about the quality of the drug itself when choosing to purchase it.